End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10 DKK | +7.53% | +0.20% | -43.66% |
04-16 | Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients | CI |
04-12 | Curasight A/S Announces Board Changes | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
26.94M | - | - | - | - | - | |
54.04B | - | |||||
41.96B | ||||||
41.92B | ||||||
28.35B | ||||||
26.35B |
- Stock Market
- Equities
- CURAS Stock
- Charts Curasight A/S
- Sector Chart